entity

O-GlcNAcylation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about O-GlcNAcylation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
0Hypotheses
1Analyses
3Outgoing
2Incoming
0Experiments

Wiki Pages (20)

Knowledge base pages for this entity

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Atypical Parkinsonism

disease · 6876 words

Alzheimer's Disease

disease · 5265 words

NDUFAF3 Gene

gene · 3956 words

Experiment Prioritization Index — Neurodegeneration

general · 3915 words

Outgoing (3)

TargetRelationTypeStr
Specificity Protein 1modulatesprotein0.87
GABARAPL1regulatesgene0.85
AMPKinhibitsprotein0.85

Incoming (2)

SourceRelationTypeStr
Glucosamineinvolved_incompound0.85
PRPS1 R196Wassociated_withprotein0.80

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Which tau PTMs are both disease-specific and druggable with selective small mole

neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.459

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found